Demethyl Naproxen Sulfate, identified by its CAS number 1246819-61-3, is a chemical compound related to the nonsteroidal anti-inflammatory drug (NSAID) naproxen. It is characterized by the presence of a sulfate group, which distinguishes it from its parent compound. The structure of Demethyl Naproxen Sulfate typically includes a naphthalene ring system, which is common in many NSAIDs, and a methoxy group that is demethylated compared to naproxen. This modification can influence its pharmacological properties, including its anti-inflammatory and analgesic activities. The compound is soluble in various organic solvents, and its solubility profile may affect its bioavailability and therapeutic efficacy. As a derivative of naproxen, it may exhibit similar mechanisms of action, primarily through the inhibition of cyclooxygenase enzymes, leading to reduced synthesis of prostaglandins involved in inflammation and pain. Further studies are often required to fully understand its pharmacokinetics, safety profile, and potential therapeutic applications.

Demethyl Naproxen Sulfate

1246819-61-3: Demethyl Naproxen Sulfate, identified by its CAS number 1246819-61-3, is a chemical compound related to the nonsteroidal anti-inflammatory drug (NSAID) naproxen. It is characterized by the presence of a sulfate group, which distinguishes it from its parent compound. The structure of Demethyl Naproxen Sulfate typically includes a naphthalene ring system, which is common in many NSAIDs, and a methoxy group that is demethylated compared to naproxen. This modification can influence its pharmacological properties, including its anti-inflammatory and analgesic activities. The compound is soluble in various organic solvents, and its solubility profile may affect its bioavailability and therapeutic efficacy. As a derivative of naproxen, it may exhibit similar mechanisms of action, primarily through the inhibition of cyclooxygenase enzymes, leading to reduced synthesis of prostaglandins involved in inflammation and pain. Further studies are often required to fully understand its pharmacokinetics, safety profile, and potential therapeutic applications.

CAS 1246819-61-3

Demethyl Naproxen Sulfate

6-Methoxy-2-naphthylacetic acid (6-MNA) sulfate

Ref: 4Z-M-353